RECRUITING

Brain Vascular and Neural Function Linked to Balance Across the Adult Lifespan

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a single-arm, two-visit, non-randomized, cross sectional study identified as an intervention due to the use of a single bout of aerobic exercise to assess cerebrovascular function under the NIH rules. This study is not masked and its primary purpose is to develop a basic science understanding of the relationship between cerebrovascular health and balance control with aging. This study will involve 102 individuals classified as younger adults, middle-aged adults, and older adults who are neurotypical and cognitively normal. The primary outcome from a clinical trials perspective will be cerebrovascular response to a bout of aerobic exercise (i.e. change in cerebral blood flow with the performance of aerobic exercise on a recumbent stepper exercise machine). Non-interventional outcomes will be EEG measures of cortical activity and biomechanical kinetic and kinematic data recorded during standing balance reactions, as well as biological blood samples for genomic analysis.

Official Title

Brain Vascular and Neural Function Linked to Balance Across the Adult Lifespan

Quick Facts

Study Start:2024-10-15
Study Completion:2028-07-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06127667

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years to 95 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age within the following 3 group age ranges, 21-30yo; middle-aged: 40-55yo; older: 65-95yo adults
  2. * the absence of major orthopedic disability
  3. * cognitively normal (MoCA score ≥ 26/30 in older adult group)
  4. * vision that is 20/40 or better with or without corrective lenses, (5) the ability to consent and communicate with researchers
  5. * English speaking
  6. * ability to stand for 3 minutes and walk 10 meters with or without an assistive device and without the assistance of another person.
  1. * insulin-dependent diabetes
  2. * peripheral neuropathy
  3. * myocardial infarction or symptoms of coronary artery disease within 2 years
  4. * congestive heart failure or class IV heart failure
  5. * any significant sensory impairment affecting balance or cognition; visual, vestibular, or auditory impairments.

Contacts and Locations

Study Contact

Jacqueline Palmer
CONTACT
240-446-1168
palmerj@umn.edu

Principal Investigator

Jacqueline Palmer
PRINCIPAL_INVESTIGATOR
University of Minnesota

Study Locations (Sites)

University of Minnesota
Minneapolis, Minnesota, 55414
United States

Collaborators and Investigators

Sponsor: University of Minnesota

  • Jacqueline Palmer, PRINCIPAL_INVESTIGATOR, University of Minnesota

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-10-15
Study Completion Date2028-07-01

Study Record Updates

Study Start Date2024-10-15
Study Completion Date2028-07-01

Terms related to this study

Additional Relevant MeSH Terms

  • Neurotypical
  • Cognitively Normal